Scalp Block Versus General Anesthesia in Patients Undergoing Evacuation of Subdural Hematoma Via Burr Hole

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorSohag University

About this trial

this study amis to compare between Scalp block versus general anesthesia in patients undergoing evacuation of subdural hematoma via burr hole.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age from 18 to 75 years old.

Both sexes.

American Society of Anesthesiologists (ASA) physical status II-III.

Patients with subdural hematoma undergoing burr-hole evacuation

Disqualifiers

Patients with a history of known sensitivity to study drugs.

Glasgow Coma Scale (GCS) <8

Impaired coagulation profile.

Any degree of heart block.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Cisatracurium

    Drug

    Induction of general anesthesia will be done by IV propofol 2-2.5 mg / kg and IV fentanyl lug/kg. After IV Cis-atracurium 0.15mg/kg, endotracheal intubation will be done.

  • scalp block

    Other intervention

    The scalp block will target six pairs of sensory nerves that innervate the scalp: the supraorbital nerve, supratrochlear nerve, auriculotemporal nerve, zygomaticotemporal nerve, greater occipital nerve, and lesser occipital nerve. Local anesthetic (2% lidocaine and bupivacaine) will be infiltrated at specific anatomical landmarks corresponding to the course of each nerve.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: 'Group A will receive general anesthesiaActive comparator 1 intervention
Group B: Group B patients will receive scalp blockActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

The aim of this prospective randomized study is to compare Scalp block versus general anesthesia in patients undergoing evacuation of subdural hematoma via burr hole.

Post operative scale by The Glasgow Coma Scale (GCS) and post operative hemodynamics.

Time frame
24 hours after operation

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.